Astrana Health, Inc. (ASTH) stock
ASTHNasdaqServices-Management Consulting ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/308% below fair value
$31.77−1.17 (-3.55%)
Close on Nov 12, 2026Market cap $1.77BP/E 29.7Yield –
Astrana Health statistics
105 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 1, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/OCF Ratio
- 15.51
- 15.92
Enterprise valuationIndustry
- EV / Sales
- 0.59
- 1.66
- EV / EBIT
- 19.08
- 19.65
- EV / FCF
- 23.25
- 22.22
Share statisticsIndustry
- Shares Change (YoY)
- 1.27%
- 1.02%
- Float
- 39M
- 29M
- Shares Held by Insiders
- 30.7%
- 4.27%
- Shares Held by Institutions
- 57.7%
- 67.7%
Short sellingIndustry
- Short Interest
- 3M
- –
- Short Interest Change
- -0.51%
- -4.60%
- Short % of Float
- 7.75%
- 5.23%
- Short % of Shares Outstanding
- 5.37%
- 3.31%
- Days to Cover
- 12.28
- 4.22
Stock price statisticsIndustry
- 52-Week High
- $51.60
- –
- 52-Week Low
- $18.08
- –
- 20-Day Moving Average
- $36.33
- –
- 50-Day Moving Average
- $36.53
- –
- 200-Day Moving Average
- $34.26
- –
- Average True Range (14)
- $2.08
- –
- Price Change (1 Week)
- -18.6%
- 0.30%
- Price Change (1 Month)
- -15.8%
- -2.01%
- Price Change (3 Months)
- -22.2%
- -4.18%
- Price Change (6 Months)
- -18.9%
- 0.09%
- Price Change (YTD)
- 28.1%
- -0.82%
- Price Change (1 Year)
- 33.5%
- -4.63%
- Price Change (3 Years)
- 1.34%
- -10.3%
- Price Change (5 Years)
- -71.1%
- -36.8%
- Price Change (10 Years)
- 606.0%
- 88.8%
- Average Volume (10 Days)
- 479,197
- –
- Average Volume (20 Days)
- 364,488
- –
- Average Volume (90 Days)
- 431,555
- –
- Relative Volume
- 0.77
- 0.68
- Relative Strength Index (14)
- 34.0
- 45.5
- Volatility (1 Year)
- 62.6%
- 62.9%
- Beta (5 Years)
- 1.20
- 0.83
MarginsIndustry
- Pretax Margin
- 2.22%
- 2.70%
- EBITDA Margin
- 4.71%
- 3.79%
- FCF Margin
- 2.54%
- 5.92%
Returns on capitalIndustry
- Return on Equity (ROE)
- 6.51%
- 1.76%
- Return on Assets (ROA)
- 2.32%
- -2.60%
- Return on Invested Capital (ROIC)
- 5.94%
- 5.25%
- Return on Capital Employed (ROCE)
- 7.78%
- 3.71%
Financial positionIndustry
- Current Ratio
- 1.25
- 1.36
- Quick Ratio
- 1.18
- 0.75
- Debt / Equity
- 1.08
- 0.45
- Debt / EBITDA
- 5.02
- 2.28
- Debt / FCF
- 9.31
- 4.31
- Net Debt / EBITDA
- 2.87
- 1.90
- Interest Coverage
- 1.87
- -0.21
GrowthIndustry
- Revenue Growth (YoY)
- 35.1%
- 5.34%
- Net Income Growth (YoY)
- 457.1%
- -2.26%
- EPS Growth (YoY)
- 435.0%
- 10.6%
- FCF Growth (YoY)
- 2.53%
- -6.06%
- Revenue Growth (3Y CAGR)
- 40.6%
- 5.14%
- Revenue Growth (5Y CAGR)
- 35.9%
- 7.65%
- EPS Growth (3Y CAGR)
- -22.5%
- 4.38%
- EPS Growth (5Y CAGR)
- -14.6%
- 9.57%
EfficiencyIndustry
- Asset Turnover
- 1.71
- 0.82
- Revenue Per Employee
- $1.30M
- $215.67K
- Profits Per Employee
- $17.71K
- -$534
- Employee Count
- 3,000
- 99
- WACC
- 8.82%
- 8.33%
Income statement (TTM)Industry
- Pretax Income
- $86.65M
- -$31.25K
Balance sheetIndustry
- Net Cash (Debt)
- -$529.15M
- $10.79K
- Net Cash Per Share
- -$9.49
- $0.00
- Equity (Book Value)
- $856.62M
- $12.47M
- Book Value Per Share
- $15.37
- $0.73
- Tangible Book Value
- -$262.30M
- $13.82K
- Working Capital
- $193.91M
- $4.10M
Cash flow (TTM)Industry
- Capital Expenditures
- -$14.78M
- -$6.55M
- FCF Per Share
- $1.78
- $0.47
Dividends and yieldsIndustry
- Earnings Yield
- 3.00%
- 0.80%
- FCF Yield
- 5.61%
- 2.65%
- Buyback Yield
- 1.07%
- 2.33%
- Shareholder Yield
- 1.07%
- 2.60%
- Payout Ratio
- 5.05%
- 44.1%
- FCF Payout Ratio
- 2.70%
- 35.6%
Taxes and interestIndustry
- Interest Expense
- $64.64M
- $468.43K
- Income Tax
- $28.23M
- $1.16M
- Effective Tax Rate
- 32.6%
- 24.1%
Scores and fair valueIndustry
- Graham Number
- $19.24
- $19.24
- Graham Upside
- -39.5%
- -52.9%
- Altman Z-Score
- 2.77
- 2.98
- Piotroski F-Score
- 4
- 5
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | ASTH | S&P 500 | Difference | ASTH per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -17.3% | -2.7% | −14.6 pts | ||
| 3 months | -11.2% | -1.7% | −9.5 pts | ||
| Year to date | +28.1% | +11.9% | +16.2 pts | ||
| 1 year | +34.8% | +12.0% | +22.9 pts | ||
| 3 years | +5.2% | +78.2% | −73.0 pts | +1.7% | +21.2% |
| 5 years | -71.1% | +73.2% | −144.3 pts | -22.0% | +11.6% |
| 10 years | +606.0% | +309.6% | +296.4 pts | +21.6% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
3M ASTH shares were sold short on Oct 30, 2026, down 0.5% from the previous report, or 7.75% of the shares available to trade. At recent volumes it would take 12.3 days to buy them back. Over the last 20 sessions, 70.6% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 2,994,790 | -0.5% | 243,777 | 12.3 |
| Oct 15, 2026 | 3,010,140 | -2.5% | 340,295 | 8.8 |
| Sep 30, 2026 | 3,087,127 | -5.7% | 531,954 | 5.8 |
| Sep 15, 2026 | 3,273,033 | -0.3% | 279,499 | 11.7 |
| Aug 31, 2026 | 3,281,911 | +3.0% | 335,914 | 9.8 |
| Aug 14, 2026 | 3,184,849 | +12.6% | 567,219 | 5.6 |
| Jul 31, 2026 | 2,827,451 | +5.5% | 573,335 | 4.9 |
| Jul 15, 2026 | 2,679,220 | +0.2% | 685,812 | 3.9 |
| Jun 30, 2026 | 2,674,196 | +13.4% | 870,387 | 3.1 |
| Jun 15, 2026 | 2,357,167 | -1.7% | 521,593 | 4.5 |
| May 29, 2026 | 2,397,686 | -11.7% | 389,740 | 6.2 |
| May 15, 2026 | 2,715,952 | -5.1% | 534,143 | 5.1 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?